242 related articles for article (PubMed ID: 10917553)
1. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
Evers R; Kool M; Smith AJ; van Deemter L; de Haas M; Borst P
Br J Cancer; 2000 Aug; 83(3):366-74. PubMed ID: 10917553
[TBL] [Abstract][Full Text] [Related]
2. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.
Evers R; de Haas M; Sparidans R; Beijnen J; Wielinga PR; Lankelma J; Borst P
Br J Cancer; 2000 Aug; 83(3):375-83. PubMed ID: 10917554
[TBL] [Abstract][Full Text] [Related]
3. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
4. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2).
Williams GC; Liu A; Knipp G; Sinko PJ
Antimicrob Agents Chemother; 2002 Nov; 46(11):3456-62. PubMed ID: 12384350
[TBL] [Abstract][Full Text] [Related]
6. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
Hyafil F; Vergely C; Du Vignaud P; Grand-Perret T
Cancer Res; 1993 Oct; 53(19):4595-602. PubMed ID: 8402633
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
Wallstab A; Koester M; Böhme M; Keppler D
Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
[TBL] [Abstract][Full Text] [Related]
9. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.
Hirai M; Tanaka K; Shimizu T; Tanigawara Y; Yasuhara M; Hori R; Kakehi Y; Yoshida O; Ueda K; Komano T
J Pharmacol Exp Ther; 1995 Oct; 275(1):73-8. PubMed ID: 7562598
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells.
Hamilton KO; Topp E; Makagiansar I; Siahaan T; Yazdanian M; Audus KL
J Pharmacol Exp Ther; 2001 Sep; 298(3):1199-205. PubMed ID: 11504821
[TBL] [Abstract][Full Text] [Related]
12. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
Hooijberg JH; Jansen G; Assaraf YG; Kathmann I; Pieters R; Laan AC; Veerman AJ; Kaspers GJ; Peters GJ
Biochem Pharmacol; 2004 Apr; 67(8):1541-8. PubMed ID: 15041471
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M
Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.
Nabekura T; Yamaki T; Ueno K; Kitagawa S
Cancer Chemother Pharmacol; 2008 Oct; 62(5):867-73. PubMed ID: 18204840
[TBL] [Abstract][Full Text] [Related]
15. Characterization of P-glycoprotein and multidrug resistance proteins in rat kidney and intestinal cell lines.
van de Water FM; Boleij JM; Peters JG; Russel FG; Masereeuw R
Eur J Pharm Sci; 2007 Jan; 30(1):36-44. PubMed ID: 17088052
[TBL] [Abstract][Full Text] [Related]
16. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
17. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
18. Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.
Salerno M; Loechariyakul P; Saengkhae C; Garnier-Suillerot A
Biochem Pharmacol; 2004 Dec; 68(11):2159-65. PubMed ID: 15498506
[TBL] [Abstract][Full Text] [Related]
19. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
Agarwal S; Pal D; Mitra AK
Int J Pharm; 2007 Jul; 339(1-2):139-47. PubMed ID: 17451894
[TBL] [Abstract][Full Text] [Related]
20. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
